Literature DB >> 10208708

Chronic critical limb ischemia: diagnosis, treatment and prognosis.

J D Santilli1, S M Santilli.   

Abstract

Chronic critical limb ischemia is manifested by pain at rest, nonhealing wounds and gangrene. Ischemic rest pain is typically described as a burning pain in the arch or distal foot that occurs while the patient is recumbent but is relieved when the patient returns to a position in which the feet are dependent. Objective hemodynamic parameters that support the diagnosis of critical limb ischemia include an ankle-brachial index of 0.4 or less, an ankle systolic pressure of 50 mm Hg or less, or a toe systolic pressure of 30 mm Hg or less. Intervention may include conservative therapy, revascularization or amputation. Progressive gangrene, rapidly enlarging wounds or continuous ischemic rest pain can signify a threat to the limb and suggest the need for revascularization in patients without prohibitive operative risks. Bypass grafts are usually required because of the multilevel and distal nature of the arterial narrowing in critical limb ischemia. Patients with diabetes are more likely than other patients to have distal disease that is less amenable to bypass grafting. Compared with amputation, revascularization is more cost-effective and is associated with better perioperative morbidity and mortality. Limb preservation should be the goal in most patients with critical limb ischemia.

Entities:  

Mesh:

Year:  1999        PMID: 10208708

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  15 in total

1.  Non-contrast-enhanced MR angiography in critical limb ischemia: performance of quiescent-interval single-shot (QISS) and TSE-based subtraction techniques.

Authors:  Mustafa A Altaha; Jeffrey D Jaskolka; Kongteng Tan; Manuela Rick; Peter Schmitt; Ravi J Menezes; Bernd J Wintersperger
Journal:  Eur Radiol       Date:  2016-06-28       Impact factor: 5.315

2.  Control of lower extremity edema in patients with diabetes: Double blind randomized controlled trial assessing the efficacy of mild compression diabetic socks.

Authors:  Stephanie C Wu; Ryan T Crews; Melissa Skratsky; Julia Overstreet; Sai V Yalla; Michelle Winder; Jacquelyn Ortiz; Charles A Andersen
Journal:  Diabetes Res Clin Pract       Date:  2017-02-27       Impact factor: 5.602

3.  Pronounced and sustained cutaneous vasoconstriction during and following cyrotherapy treatment: Role of neurotransmitters released from sympathetic nerves.

Authors:  Kevin M Christmas; Jordan C Patik; Sepideh Khoshnevis; Kenneth R Diller; R Matthew Brothers
Journal:  Microvasc Res       Date:  2017-08-24       Impact factor: 3.514

4.  Sustained cutaneous vasoconstriction during and following cyrotherapy treatment: Role of oxidative stress and Rho kinase.

Authors:  Kevin M Christmas; Jordan C Patik; Sepideh Khoshnevis; Kenneth R Diller; R Matthew Brothers
Journal:  Microvasc Res       Date:  2016-04-14       Impact factor: 3.514

5.  Tumor necrosis factor inhibition increases the revascularization of ischemic hind-limbs in diabetic mice.

Authors:  Adel M A Assiri; Hatim A El-Baz; Ali H Amin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-05-31       Impact factor: 3.000

6.  Cell Therapy and Critical Limb Ischemia: Evidence and Window of Opportunity in Obesity.

Authors:  Sally L Elshaer; Renee E Lorys; A B El-Remessy
Journal:  Obes Control Ther       Date:  2016-09-15

7.  A multivariate model for the meta-analysis of study level survival data at multiple times.

Authors:  Dan Jackson; Katie Rollins; Patrick Coughlin
Journal:  Res Synth Methods       Date:  2014-02-27       Impact factor: 5.273

Review 8.  A review of the pathophysiology and potential biomarkers for peripheral artery disease.

Authors:  Smriti Murali Krishna; Joseph V Moxon; Jonathan Golledge
Journal:  Int J Mol Sci       Date:  2015-05-18       Impact factor: 5.923

9.  Leucine-Rich α-2-Glycoprotein 1 Suppresses Endothelial Cell Activation Through ADAM10-Mediated Shedding of TNF-α Receptor.

Authors:  Kuin Tian Pang; Mean Ghim; Chenghao Liu; Hui Min Tay; Chee Wai Fhu; Rui Ning Chia; Beiying Qiu; Padmini Sarathchandra; Adrian H Chester; Magdi H Yacoub; Fiona L Wilkinson; Ria Weston; Christina M Warboys; Han Wei Hou; Peter D Weinberg; Xiaomeng Wang
Journal:  Front Cell Dev Biol       Date:  2021-07-05

10.  Laser in-situ keratomileusis in patients with diabetes mellitus: a review of the literature.

Authors:  Rachel G Simpson; Majid Moshirfar; Jason N Edmonds; Steven M Christiansen
Journal:  Clin Ophthalmol       Date:  2012-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.